The bill S. 4808 aims to update the Federal Credit Union Act to improve the process for privately insured credit unions that wish to convert to federal insurance. This modernization is intended to streamline the conversion process, making it easier for these credit unions to transition to a federally insured status.
Supporters of S. 4808 argue that modernizing the conversion process for privately insured credit unions will enhance consumer protection and provide more stability in the financial system. They believe that this bill will encourage more credit unions to seek federal insurance, which could ultimately benefit members by offering greater security.
Critics of S. 4808 express concerns that the bill may weaken the independence of privately insured credit unions by pushing them towards federal insurance. Some argue that it could lead to a one-size-fits-all approach that undermines the unique needs and preferences of these credit unions and their members.
The bill S. 4808 aims to amend the Federal Credit Union Act concerning conversion modernization for privately insured credit unions. While there are no direct industry overlaps between the bill's subject matter and the sponsor's top donor industries, there is notable lobbying activity in related financial sectors. For instance, Intermountain Health and Vertex Pharmaceuticals have contributed significant amounts ($50,000 and $60,000, respectively) to lobbying efforts that could indirectly influence credit union operations. The presence of these contributions suggests a potential for conflicts of interest, particularly if the bill's amendments could favor certain financial practices that benefit these industries. Voters should be aware that while direct conflicts are not evident, the financial ties to lobbying groups in the healthcare and telecommunications sectors could create indirect pressures on the bill's outcomes.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | MARSHALL & POPP, LLC | $60,000 |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | MARSHALL & POPP, LLC | $60,000 |
| INTERMOUNTAIN HEALTH | MCDERMOTT WILL & SCHULTE LLP | $50,000 |
| WAYFINDER GROUP (OBO RESEARCH CORPORATION OF THE UNIVERSITY OF HAWAII) | RED MAPLE CONSULTING, LLC | $40,000 |
| FRONTIER INFRASTRUCTURE HOLDINGS LLC | KOUNTOUPES DENHAM CARR & REID, LLC | $30,000 |
| ECKERD CONNECTS | KOUNTOUPES DENHAM CARR & REID, LLC | $30,000 |
| SMART APPROACHES TO MARIJUANA | OFF HILL STRATEGIES L.L.C. | $20,000 |
| FEDERATION OF ELECTRIC POWER COS OF JAPAN | GEORGE H. DENISON | $10,000 |
| MAYO CLINIC | MCDERMOTT WILL & SCHULTE LLP | undisclosed |
| VERIZON COMMUNICATIONS, INC. | MARSHALL & POPP, LLC | undisclosed |
| THE BIG TEN CONFERENCE, INC. | MARSHALL & POPP, LLC | undisclosed |
| THE BIG 12 CONFERENCE, INC. | MARSHALL & POPP, LLC | undisclosed |
| SOUTHEASTERN CONFERENCE | MARSHALL & POPP, LLC | undisclosed |
| PAC-12 CONFERENCE | MARSHALL & POPP, LLC | undisclosed |
| ATLANTIC COAST CONFERENCE | MARSHALL & POPP, LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Catherine Cortez Masto, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
